Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Ambulatory Coronary Angiography: Is any further evidence required?

Original title: Same-Day Discharge Compared With Overnight Hospitalization After Uncomplicated Percutaneous Coronary Intervention. A Systematic Review and Meta-Analysis Reference: Eltigani Abdelaal et al. J Am Coll Cardiol Intv 2013. Article in press.

Coronary angioplasty and subsequent same day discharge in selected patients can reduce costs and increase patient comfort. 

Several observational studies and a few randomized studies have described the safety of same day discharge, however, opinions still vary extensively among the different centers. In an attempt to answer these questions, a meta analysis was carried out to evaluate the total incidence of complications, major cardiovascular events (MACE) and rehospitalization at 30 days.

13 studies were analyzed (5 randomized and 8 observational) with a total of 111830 patients. 96% of procedures were approach by femoral access and 83% of patients were discharged the same day. The median permanence time of same day discharged patients was 4 to 8 hrs.

In randomized studies there were no significant differences in the total number of complications between same day discharged patients and those patients that remained hospitalized (6.5% vs. 5.5% respectively; OR:1.2, 95% IC:0.82 -1.01). At 30 days, MACE incidence in randomized studies was identical in both groups (1.3%), rehospitalizations show no differences as well (4% vs. 3.6%; OR 1.1, 95%IC: 0.7-1.7). Observational studies reached similar conclusions in all the above mentioned.

Conclusion:

The heterogeneous nature of these studies call for a randomized study to assess the correct strategy. Until then, same day discharge after non complicated angioplasty is reasonable in selected patients.

Editorial Comment: 

The randomized study that in theory would be necessary to reach a definite valid conclusion should include more than 17,000 patients to reach enough statistic power seeing the low frequency of these events. It is highly unlikely that we will count on this information in a near future, if ever available. Even though the use of the radial artery is less than 5%, if we exclude the analysis of observational studies performed in the USA (Rao et al., among others) the radial approach reaches almost 50% of cases, which speaks for the low preference of this approach in this country. Seeing the main reasons behind same day discharge are cost reduction and patient comfort, the radial approach seems the most sensible choice.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...